Acute cholecystitis in neutropenic patients
| Autor: | Heriberto Medina-Franco, Ismael Dominguez-Rosado, Paulina Moctezuma Velazquez, German Esteban Sánchez Morales, Alexandra Rueda de León Aguirre, Jesus Morales Maza, Uriel Clemente-Gutiérrez |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
education.field_of_study
medicine.medical_specialty Leukemia Neutropenia Septic shock business.industry medicine.medical_treatment Population medicine.disease Tertiary referral hospital Hematologic disease Internal medicine Cholecystostomy medicine Cholecystitis General Materials Science Cholecystectomy Original Article education business |
| Zdroj: | Annals of Hepato-Biliary-Pancreatic Surgery |
| ISSN: | 2508-5859 2508-5778 |
| Popis: | Backgrounds/aims The frequency of acute cholecystitis reported in neutropenic patients is between 0.4-1.65%. Clinical manifestations differ from general population as well as clinical approach, diagnosis and treatment. The aim of this work is to describe clinical characteristics, diagnostic approach, and outcomes of patients with hematological diseases that presented with neutropenia and fever associated with acute cholecystitis in a tertiary referral hospital. Methods We performed a retrospective analysis of patients with diagnosis of neutropenia and fever associated with acute cholecystitis in the period between January 2000 and January 2017. Quantitative variables were analyzed with mean and standard deviation, and qualitative variables with frequency and percentage. Results During the study period, 2007 patients presented with neutropenia and fever. Twelve of them (0.59%) had associated acute cholecystitis. The most common hematologic disease among these patients was lymphoblastic leukemia. Acute acalculous cholecystitis was diagnosed in 6 cases (50%). Eleven patients (91.6%) had a severe presentation and cholecystostomy was performed in 9 (75%) cases. The main cause of mortality was septic shock (33.3%). Conclusions Treatment of acute cholecystitis in patients with neutropenia must be individualized. Cholecystostomy should be considered as a bridge therapy for an interval cholecystectomy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|